Larvol Delta - Affimed-Announces-Positive-Data-for-AFM24-in-Combination-with-the-PDL1-Checkpoint-Inhibitor-Atezolizumab-in-Heavily-Pretreated-EGFRWildtype-NonSmall-Cell-Lung-Cancer-Patients

AFM24 - Affimed

https://www.globenewswire.com/news-release/2023/12/11/2793678/0/en/Affimed-Announces-Positive-Data-for-AFM24-in-Combination-with-the-PD-L1-Checkpoint-Inhibitor-Atezolizumab-in-Heavily-Pre-treated-EGFR-Wildtype-Non-Small-Cell-Lung-Cancer-Patients.html

Dec 11, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next